Phibro Animal Health (PAHC) After Russell Index Removals And The Case For Undervaluation

Simply Wall St.

Jul 10

AdvertisementWhy Phibro Animal Health is in focus after Russell index removals Phibro Animal Health (PAHC) has come into focus after being removed from several Russell indices, including the Russell ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2650904544"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2650904544\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2650904544?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","is_english":true,"pubTime":"2026-07-10 13:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2650904544","market":"nz","top_or_hot":-1,"title":"Phibro Animal Health (PAHC) After Russell Index Removals And The Case For Undervaluation","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementWhy Phibro Animal Health is in focus after Russell index removals Phibro Animal Health (PAHC) has come into focus after being removed from several Russell indices, including the Russell ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pahc/phibro-animal-health/news/phibro-animal-health-pahc-after-russell-index-removals-and-t\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Phibro Animal Health (PAHC) After Russell Index Removals And The Case For Undervaluation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPhibro Animal Health (PAHC) After Russell Index Removals And The Case For Undervaluation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-10 13:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pahc/phibro-animal-health/news/phibro-animal-health-pahc-after-russell-index-removals-and-t><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementWhy Phibro Animal Health is in focus after Russell index removals Phibro Animal Health (PAHC) has come into focus after being removed from several Russell indices, including the Russell ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pahc/phibro-animal-health/news/phibro-animal-health-pahc-after-russell-index-removals-and-t\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pahc/phibro-animal-health/news/phibro-animal-health-pahc-after-russell-index-removals-and-t","article_id":"2650904544","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pahc/phibro-animal-health/news/phibro-animal-health-pahc-after-russell-index-removals-and-t","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2650904544","pubTimestamp":1783659609,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Why Phibro Animal Health is in focus after Russell index removals\nPhibro Animal Health (PAHC) has come into focus after being removed from several Russell indices, including the Russell 3000E and Microcap benchmarks, a change that directly affects its index fund exposure.\nThese index removals can prompt mechanical buying or selling by funds that track or reference the affected benchmarks, which can influence trading volumes around the event date rather than reflecting any shift in Phibro...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","PAHC":"Phibro Animal Health Corporation"},"translate_title":"罗素指数删除后的 Phibro Animal Health (PAHC) 以及被低估的情况","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PAHC":1.5},"content_text":"AdvertisementWhy Phibro Animal Health is in focus after Russell index removals Phibro Animal Health (PAHC) has come into focus after being removed from several Russell indices, including the Russell 3000E and Microcap benchmarks, a change that directly affects its index fund exposure. These index removals can prompt mechanical buying or selling by funds that track or reference the affected benchmarks, which can influence trading volumes around the event date rather than reflecting any shift in Phibro Animal Health’s underlying operations. For you as an individual investor, the key question is how this technical change interacts with a stock that already has a long multi year return record and currently appears relatively inexpensive on several valuation checks. See our latest analysis for Phibro Animal Health. Phibro Animal Health’s share price has slipped about 44% over the past 90 days and is down 13.19% year to date. However, the 3 year total shareholder return of 135.93% and 5 year total shareholder return of 47.11% point to a strong longer term record, suggesting recent index removals and shorter term price pressure are cooling momentum rather than redefining the story overnight. If this kind of technical selling has you thinking about where else capital might rotate, it could be a good moment to see what is moving in 18 top founder-led companies Bulls view Phibro Animal Health’s long multi year gains and value score of 5 as an opportunity to buy on a pullback, while bears highlight index removals and recent share price pressure. Which case does the current valuation appear to support next? Most Popular Narrative: 29% Undervalued On the narrative view, Phibro Animal Health’s fair value of $45.60 sits well above the last close at $32.38, putting analyst expectations in sharp focus.  The company's strong recent growth is heavily dependent on the integration of the acquired Zoetis Medicated Feed Additive business and related cost synergies, which are non repeatable. Forward guidance suggests legacy product growth will slow to flat or low single digits. This implies the current trajectory of accelerating revenue and EBITDA growth is unsustainable and likely to normalize, impacting revenue and earnings growth expectations.  Read the complete narrative. Analysts are building this Phibro Animal Health narrative on moderate top line assumptions, expanding margins, and a future earnings multiple that still sits below sector benchmarks. Curious which levers matter most and how they connect to that fair value gap. Result: Fair Value of $45.60 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, this Phibro Animal Health story could change quickly if regulatory pressure on antimicrobials, or faster adoption of alternative proteins, reduces the long term livestock market. Find out about the key risks to this Phibro Animal Health narrative. Next Steps Given the mixed sentiment around Phibro Animal Health, with both risks and rewards in play, it is important to act promptly and evaluate the trade off yourself with 4 key rewards and 2 important warning signs Looking for more ideas beyond Phibro Animal Health? If Phibro Animal Health has sharpened your focus on valuation, do not stop here, fresh opportunities could be passing you by while attention stays on one stock.  Spot potential bargains early by reviewing 44 high quality undervalued stocks before others price in their strengths. Secure potential income streams by scanning 9 dividend fortresses that offer substantial yields with staying power. Prioritize resilience by focusing on 73 resilient stocks with low risk scores that aim to keep drawdowns in check when conditions get tougher.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}